| pubmed-article:10481064 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C0162740 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C1708096 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C0547040 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C1515877 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:10481064 | lifeskim:mentions | umls-concept:C0311667 | lld:lifeskim |
| pubmed-article:10481064 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10481064 | pubmed:dateCreated | 1999-10-13 | lld:pubmed |
| pubmed-article:10481064 | pubmed:abstractText | The Arabidopsis thaliana gene that encodes pyrroline-5-carboxylate reductase (At-P5R), the last enzyme in proline biosynthesis in A. thaliana, is developmentally regulated and is highly expressed in cells that divide rapidly or undergo changes in osmotic potential. A 69 bp region (P69; -120 to -51) has previously been identified in a 5' deletion analysis of the At-P5R promoter to be necessary for the basal expression. Here, the essential role of P69 for tissue-specific expression of At-P5R is demonstrated by loss- and gain-of-function experiments. | lld:pubmed |
| pubmed-article:10481064 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10481064 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10481064 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10481064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10481064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10481064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10481064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10481064 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10481064 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10481064 | pubmed:issn | 0014-5793 | lld:pubmed |
| pubmed-article:10481064 | pubmed:author | pubmed-author:Van MontaguMM | lld:pubmed |
| pubmed-article:10481064 | pubmed:author | pubmed-author:HugVV | lld:pubmed |
| pubmed-article:10481064 | pubmed:author | pubmed-author:VerbruggenNN | lld:pubmed |
| pubmed-article:10481064 | pubmed:author | pubmed-author:van de... | lld:pubmed |
| pubmed-article:10481064 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10481064 | pubmed:day | 17 | lld:pubmed |
| pubmed-article:10481064 | pubmed:volume | 458 | lld:pubmed |
| pubmed-article:10481064 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10481064 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10481064 | pubmed:pagination | 193-6 | lld:pubmed |
| pubmed-article:10481064 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:meshHeading | pubmed-meshheading:10481064... | lld:pubmed |
| pubmed-article:10481064 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10481064 | pubmed:articleTitle | A 69 bp fragment in the pyrroline-5-carboxylate reductase promoter of Arabidopsis thaliana activates minimal CaMV 35S promoter in a tissue-specific manner. | lld:pubmed |
| pubmed-article:10481064 | pubmed:affiliation | Laboratorium voor Genetica, Departement Plantengenetica, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), Universiteit Gent, Belgium. | lld:pubmed |
| pubmed-article:10481064 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10481064 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10481064 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
